ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,871.60
0.25%
S&P ASX All Technology
3,084.80
0.22%
Brent Oil
82.375
-0.08%
US Dollar vs AUD
1.49975
-0.01%
Bitcoin
70,141.87
0.02%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Ambrx Biopharma Inc (AMAM)

  7. Ambrx Biopharma Inc (AMAM) News

AMAM

Ambrx Biopharma (AMAM)

Ambrx Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:AMAM
DateTimeSourceHeadlineSymbolCompany
13/10/202307:20Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:AMAMAmbrx Biopharma Inc
13/10/202307:15Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:AMAMAmbrx Biopharma Inc
13/10/202307:10Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:AMAMAmbrx Biopharma Inc
13/10/202307:05Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNYSE:AMAMAmbrx Biopharma Inc
12/10/202321:04Edgar (US Regulatory)Form 8-K - Current reportNYSE:AMAMAmbrx Biopharma Inc
11/10/202307:49Edgar (US Regulatory)Form 8-K - Current reportNYSE:AMAMAmbrx Biopharma Inc
11/10/202302:35Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:AMAMAmbrx Biopharma Inc
07/10/202307:07Edgar (US Regulatory)Form 8-K - Current reportNYSE:AMAMAmbrx Biopharma Inc
26/09/202307:24Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNYSE:AMAMAmbrx Biopharma Inc
08/07/202306:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:AMAMAmbrx Biopharma Inc
29/06/202306:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:AMAMAmbrx Biopharma Inc
29/06/202306:07Edgar (US Regulatory)Current Report Filing (8-k)NYSE:AMAMAmbrx Biopharma Inc
10/06/202306:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:AMAMAmbrx Biopharma Inc
10/06/202306:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:AMAMAmbrx Biopharma Inc
10/06/202306:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:AMAMAmbrx Biopharma Inc
10/06/202306:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:AMAMAmbrx Biopharma Inc
09/06/202306:06Edgar (US Regulatory)Current Report Filing (8-k)NYSE:AMAMAmbrx Biopharma Inc
26/05/202306:08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NYSE:AMAMAmbrx Biopharma Inc
19/05/202306:28Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NYSE:AMAMAmbrx Biopharma Inc
19/05/202306:24Edgar (US Regulatory)Current Report Filing (8-k)NYSE:AMAMAmbrx Biopharma Inc
17/05/202306:07Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NYSE:AMAMAmbrx Biopharma Inc
12/05/202306:08Edgar (US Regulatory)Quarterly Report (10-q)NYSE:AMAMAmbrx Biopharma Inc
06/05/202306:10Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:AMAMAmbrx Biopharma Inc
06/05/202306:06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NYSE:AMAMAmbrx Biopharma Inc
05/05/202306:12Edgar (US Regulatory)Current Report Filing (8-k)NYSE:AMAMAmbrx Biopharma Inc
29/04/202308:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:AMAMAmbrx Biopharma Inc
29/04/202308:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:AMAMAmbrx Biopharma Inc
29/04/202306:22Edgar (US Regulatory)Annual Report to Security Holders (ars)NYSE:AMAMAmbrx Biopharma Inc
29/04/202306:09Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:AMAMAmbrx Biopharma Inc
28/04/202306:11Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:AMAMAmbrx Biopharma Inc
 Showing the most relevant articles for your search:NYSE:AMAM

Your Recent History

ASX
BHP
BHP
FX
EURAUD
Euro vs AUD
FX
AUDCAD
AUD vs CAD
ASX
WOW
Woolworths
ASX
QBE
QBE Insurance
NYSE
JPM
JP Morgan Chase
ASX
WES
Wesfarmers
NASDAQ
MSFT
Microsoft
ASX
WBC
Westpac Banking
NYSE
KO
Coca Cola
ASX
ORG
Origin Energy
NYSE
MRK
Merck
ASX
WDC
Westfield
ASX
SUN
Suncorp
ASX
MQG
Macquarie
FX
GBPAUD
Sterling vs AUD
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved